Posted in | News | Rubber and Elastomer

Lanxess Plans Largest Investment in Its History with Butyl Rubber Expansions in Mind

Chemical group LANXESS seeks to expand its global position in the butyl rubber market and is pursuing plans to build a new facility in Asia. “This would be the largest investment in the history of our company,” said LANXESS Management Board Chairman Axel C. Heitmann during a visit to Singapore. „In the next few months we will hold talks with possible host locations to determine the feasibility of the construction of a new plant. Should we decide upon a location, we will be able to bring the facility on stream in 2010.” LANXESS projects an investment of a magnitude of EUR 400 million. Negotiations at three possible sites, Singapore, Kuantan in Malaysia and Map Ta Phut in Thailand, will begin immediately. In the last several months, LANXESS has analyzed sites across Asia to assess their feasibility.

LANXESS is focused on satisfying the growing demand for butyl rubber in Asia. Tire production will continue to be the main use of butyl. LANXESS’s potential investment is designed to serve tire production which is increasingly shifting from the US and Western Europe to Asia. Additionally, the capacities of local Asian manufacturers are rapidly increasing.

LANXESS intends to increase sales in Asia in the future through continued cooperation with global customers and pursuing growth with local partners. Following the completion of the expansion of the Zwijndrecht site in Belgium and the expansion in butyl rubber capacity currently being executed at LANXESS’s site in Sarnia, Canada, the commissioning of a new facility in Asia could be another milestone on the road to further profitable growth.

The Butyl Rubber Business Unit belongs to the Performance Rubber segment, which achieved total sales in 2006 of EUR 1,776 million.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.